# US 2021/0275506 A1 · Compositions and methods of treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275506 A1
- Document ID: US20210275506A1
- Status: Published application
- Kind: A1
- Application number: 17/257,423
- Filed: 2019-07-03
- Published: 2021-09-09
- Earliest claimed: 2018-07-03
- Applicants: Blueberry Therapeutics Limited
- Inventors: Christine Ridden; John Ridden; David Cook
- Web page: https://patentgrep.com/patent/US20210275506A1

## CPC

- A61K 31/436: the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A61P 17/10: Anti-acne agents
- A61K 9/1641: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers}
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 31/196: the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A61K 38/13: Cyclosporins
- A61P 17/00: Drugs for dermatological disorders
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to compositions for use in the treatment of a dermatological condition, comprising a polymer capable of forming nanoparticles an anti-inflammatory and/or analgesic agent. The composition is particularly suited to the treatment of acne and/or atopic dermatitis. The invention also relates to novel uses of polyhexamethylene biguanide.

## Claims

### Claim 1

A composition for use in the treatment of a dermatological condition, comprising a polymer capable of forming nanoparticles and an anti-inflammatory and/or analgesic agent.

### Claim 2 (depends on 1)

The composition as claimed in claim 1, wherein the polymer comprises a linear and/or branched or cyclic polymonoguanide/polyguanidine, polybiguanide, analogue or derivative thereof.

### Claim 3 (depends on 1, 2)

The composition as claimed in either claim 1 or 2, wherein the polymer comprises polyhexamethylene biguanide.

### Claim 4

The composition as claimed in any preceding claim, wherein the nanoparticles are formed with and/or in the presence of the anti-inflammatory and/or analgesic agent.

### Claim 5

The composition as claimed in any preceding claim, wherein the anti-inflammatory agent comprises a non-steroidal anti-inflammatory (NSAID) agent.

### Claim 6

The composition as claimed in any preceding claim, wherein the anti-inflammatory agent comprises one or more selected from the following: Rapamycin, Tacrolimus, Ibuprofen, Ciclosporin, Diclofenac, Naproxen and related derivatives and salts thereof.

### Claim 7

The composition as claimed in any preceding claim, wherein the composition further comprises one or more of the following component: buffers, excipients, binders, oils, water, emulsifiers, glycerin, antioxidants, preservatives and fragrances.

### Claim 8

The composition as claimed in any preceding claim, wherein the composition is in the form of a topical medicament.

### Claim 9

The composition as claimed in any preceding claim, wherein the dermatological condition comprises acne and/or atopic dermatitis or related conditions.

### Claim 10

A composition as claimed in any preceding claim, wherein the composition is in the form of a cream, ointment, spray, powder, foam or mousse.

### Claim 11

Use of polyhexamethylene biguanide (PHMB) to form one or more nanoparticles with, or associated with, an anti-inflammatory and/or analgesic agent in the preparation of a medicament for the treatment of a dermatological condition.

### Claim 12 (depends on 11)

Use of PHMB as claimed in claim 11, wherein the nanoparticles are used as the delivery vehicle for anti-inflammatory and/or analgesic agent to an affected dermatological area.

### Claim 13 (depends on 11, 12)

Use of PHMB as claimed in claim 11 or 12, wherein the dermatological condition comprises acne and/or atopic dermatitis or related conditions.

### Claim 14 (depends on 11, 12, 13)

Use of PHMB as claimed in any one of claims 11 to 13, wherein the anti-inflammatory and/or analgesic agent comprises a non-steroidal anti-inflammatory (NSAID) agent.

### Claim 15 (depends on 11, 12, 13, 14)

Use of PHMB as claimed in any one of claims 11 to 14, wherein the anti-inflammatory and/or analgesic agent comprises one or more selected from the following: Rapamycin, Tacrolimus, Ibuprofen, Ciclosporin, Diclofenac, Naproxen and related derivatives and salts thereof.

### Claim 16

A method of producing a composition for the treatment of a dermatological condition comprising mixing a polymer capable of forming nanoparticles with an anti-inflammatory and/or analgesic agent under conditions suitable to allow the formation of nanoparticles.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 16)

The method as claimed in claim 16, wherein the method is used to produce a composition as claimed in any one of claims 1 to 10.
